SynthesisBreast cancer research : BCR2022

Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer.

Lulu Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.